Zobrazeno 1 - 5
of 5
pro vyhledávání: '"S. J. Chadban"'
Autor:
M L R, Wyld, C M Y, Lee, X, Zhuo, S, White, J E, Shaw, R L, Morton, S, Colagiuri, S J, Chadban
Publikováno v:
Internal medicine journal. 45(7)
Costs associated with chronic kidney disease (CKD) are not well documented. Understanding such costs is important to inform economic evaluations of prevention strategies and treatment options.To estimate the costs associated with CKD in Australia.We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bb4a27ca53d4f637d7ed9e1acced7596
https://pubmed.ncbi.nlm.nih.gov/25944415
https://pubmed.ncbi.nlm.nih.gov/25944415
Autor:
T. C. Turin, K. Matsushita, J. Coresh, H. Arima, S. J. Chadban, M. Cirillo, O. Djurdjev, J. A. Green, F. Irie, J. H. Ix, C. P. Kovesdy, T. Ohkubo, A. Shankar, C. P. Wen, P. E. De Jong, K. Iseki, B. Stengel, R. T. Gansevoort, L. De Nicola, C. Donfrancesco, R. Minutolo, L. Iacoviello, C. Zoccali, L. Gesualdo, G. Conte, D. Vanuzzo, S. Giampaoli, J. L. Gorriz, P. Molina-Vila, J. Nieto, J. Bover, A. Martinez-Castelao, A. L. Martinde Francisco, G. Barril, M. D. Del Pino, V. Escudero, Y. Sang, S. H. Ballew, L. J. Appel, G. H. Heine, L. A. Inker, A. Ishani, A. Marks, V. Shalev, A. S. Levey, S. Sedaghat, F. U. S. Mattace-Raso, A. G. Uitterlinden, E. J. Hoorn, A. Hofman, M. A. Ikram, O. H. Franco, A. Dehghan
Publikováno v:
Nephrology Dialysis Transplantation. 29:iii54-iii55
METHODS: Change in eGFR was estimated as % change from the first to last eGFR (CKD-EPI creatinine) in a 2-year baseline period. We modeled the hazard ratios (HRs) of subsequent mortality as a spline function of % change in eGFR after adjusting for ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3e3603993142203109bb4599db33734
https://doi.org/10.1093/ndt/gfu134
https://doi.org/10.1093/ndt/gfu134
Publikováno v:
The Cochrane database of systematic reviews. (1)
Lupus nephritis is the renal manifestation of systemic lupus erythematosus (SLE) - a disease mainly affecting young women with substantial morbidity and mortality. It is classified by the World Health Organization (WHO) criteria I - VI based on histo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::94a9d7c226cc0a1b8673819473c9f81b
https://pubmed.ncbi.nlm.nih.gov/23235592
https://pubmed.ncbi.nlm.nih.gov/23235592
Autor:
F G, Brown, D J, Nikolic-Paterson, S J, Chadban, J, Dowling, M, Jose, C N, Metz, R, Bucala, R C, Atkins
Publikováno v:
Transplantation. 71(12)
Macrophage migration inhibitory factor (MIF) is a pro-inflammatory cytokine that is a potent activator of macrophages and T cells. Previous studies have shown that local MIF production is increased in acute renal allograft rejection, suggesting that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a8966806f33e194c0f3c51aa4057e8b6
https://pubmed.ncbi.nlm.nih.gov/11455258
https://pubmed.ncbi.nlm.nih.gov/11455258
Publikováno v:
Laboratory investigation; a journal of technical methods and pathology. 76(5)
Macrophages are involved in the pathogenesis of mesangioproliferative glomerulonephritis. As macrophages are known to produce interleukin-10 (IL-10), we investigated the effect of recombinant murine IL-10 (rIL-10) on mesangial cell growth. In vitro s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::113adb2e4ed5598f7a526181d15a5b00
https://pubmed.ncbi.nlm.nih.gov/9166281
https://pubmed.ncbi.nlm.nih.gov/9166281